Induction of apoptosis and growth inhibition by silodosin and abiraterone acetate in PC-3 human prostate cancer cells
Purpose: Prostate cancer that progresses despite androgen deprivation therapy, known as metastatic castration-resistant prostate cancer (mCRPC) is notoriously difficult to treat. While abiraterone acetate (AA) is a standard therapy, repurposing drugs like silodosin, a selective α1A-adrenoceptor anta...
Kaydedildi:
| Asıl Yazarlar: | , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Korean Urological Association
2025-11-01
|
| Seri Bilgileri: | Investigative and Clinical Urology |
| Konular: | |
| Online Erişim: | https://www.icurology.org/pdf/10.4111/icu.20250310 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|